Trials / Completed
CompletedNCT04787549
Effect of Immersive Virtual Reality Exergames in Patients With Parkinson's Disease
Effect of Cognitively Challenging Exergames Using Fully Immersive Virtual Reality in Patients With Parkinson's Disease: A Pilot Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- Seoul National University Hospital · Academic / Other
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
The study aimed to investigate the effect of applying cognitively challenging exergames using fully immersive virtual reality in patients with Parkinson's disease.
Detailed description
It has been reported that dual-task training involving both cognitive and physical functions helps improve walking speed during dual-task performance without increasing the fall risk in patients with Parkinson's disease (PD). Compared with conventional physical therapy, there are studies that dual-task training significantly improved walking speed and stride in PD patients. In addition, a systematic review study has been reported that it helps to improve balance and cognitive function when dual-task training is performed for patients with neurological diseases including Parkinson's disease. Virtual reality is expected to promote functional recovery in patients with neurological disorders in terms of providing an enriched environment, goal-directed tasks and repetition, and inducing interest and motivation. Therefore, the study aimed to investigate the effect of applying cognitively challenging exergames using fully immersive virtual reality in patients with PD.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Virtual reality exergames | A total of 10 sessions were held for 30 minutes, 2 to 3 times a week for exergames using fully immersive virtual reality under the assistance of an occupational therapist. |
Timeline
- Start date
- 2021-07-20
- Primary completion
- 2022-01-27
- Completion
- 2022-01-27
- First posted
- 2021-03-08
- Last updated
- 2022-01-28
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT04787549. Inclusion in this directory is not an endorsement.